CRL vs DHR
Charles River Laboratories (CRL) and Danaher (DHR) compared side by side. Danaher (DHR) is larger, with a market cap of $162.0B versus $16.6B for Charles River Laboratories, about 9.7 times the size. CRL returned +80.9% over the past year including dividends, versus +4.3% for DHR, through October 23, 2026..
Head to head
| Metric | CRL | DHR |
|---|---|---|
| Market cap | $16.6B | $162.0B |
| P/E (TTM) | — | 38.2x |
| Forward P/E | 27.1x | 24.8x |
| Revenue (TTM) | $4.0B | $25.6B |
| Revenue growth | -2.7% | 8.3% |
| Gross margin | 34.6% | 59.4% |
| Operating margin | 15.1% | 21.1% |
| Free cash flow | $370.6M | $5.5B |
| Dividend yield | None | 0.69% |
| 1-year return | +80.9% | +4.3% |
| 5-year return (annual) | -3.9% | -3.2% |
| Max drawdown | -78% | -65% |
| FI Handbook grade | C- | C+ |
Highlighted: the stronger figure on metrics where higher or lower is clearly better.
Growth of $10,000 (5 years, price only)
$2.5K
$5.0K
$7.5K
$10.0K
20222023202420252026
CRL vs DHR FAQ
Which is bigger, CRL or DHR?
Danaher (DHR) is larger, with a market cap of $162.0B versus $16.6B for Charles River Laboratories, about 9.7 times the size.
Which stock performed better over the past year, CRL or DHR?
CRL returned +80.9% over the past year including dividends, versus +4.3% for DHR, through October 23, 2026.
Which pays a higher dividend, CRL or DHR?
DHR yields 0.69%; CRL does not pay a dividend.
Full pages: Charles River Laboratories · Danaher